Paulson & Co amasses large stake in Allergan: Reuters
Hedge fund Paulson & Co has amassed a large stake in Allergan Inc of more than 6 million shares and supports a deal between the Botox maker and Valeant Pharmaceuticals Inc, Reuters reported. Valeant and its ally, Pershing Square Capital Management, are seeking to call a meeting to elect new directors to Allergan's board, which could pave the way for a takeover of the company. The Canadian drugmaker has taken its offer directly to Allergan shareholders after Allergan rejected its latest US$53 billion takeover bid.
27 June 2014•3 mins read
